These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 1520622)

  • 1. Remission with morphological myelodysplasia in de novo acute myeloid leukaemia: implications for early relapse.
    Nagai K; Matsuo T; Atogami S; Moriuchi Y; Yoshida Y; Kuriyama K; Tomonaga M
    Br J Haematol; 1992 May; 81(1):33-9. PubMed ID: 1520622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significance of trilineage myelodysplasia in de novo acute myeloid leukaemia during remission rather than at diagnosis.
    Tamura S; Takemoto Y; Wada H; Itoh T; Mori A; Saheki K; Okada M; Takatsuka H; Fujimori Y; Okamoto T; Kakishita E
    Br J Haematol; 1998 Jun; 101(4):743-8. PubMed ID: 9674749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clonal evolutions during long-term cultures of bone marrow from de novo acute myeloid leukaemia with trilineage myelodysplasia and with myelodysplastic remission marrow.
    Tamura S; Kanamaru A; Takemoto Y; Kakishita E; Nagai K
    Br J Haematol; 1993 Jun; 84(2):219-26. PubMed ID: 8398821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical significance of micromegakaryocytes in de novo AML].
    Kobayashi S; Seki K; Katayama N; Akiba C; Yamamoto T; Sakai K; Yamaguchi M; Maruta A; Noguchi T; Ogawa K
    Rinsho Ketsueki; 1993 Mar; 34(3):313-20. PubMed ID: 8479083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clonal remissions in acute myeloid leukaemia are commonly associated with features of trilineage myelodysplasia during remission.
    Jowitt SN; Liu Yin JA; Saunders MJ; Lucas GS
    Br J Haematol; 1993 Dec; 85(4):698-705. PubMed ID: 7918032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Morphological comparison of dysplastic changes between de novo acute myeloid leukemia (AML) with trilineage myelodysplasia and AML developed from de novo myelodysplastic syndromes.
    Kuriyama K; Miyazaki Y; Arimura K; Nagai K; Nakamura H; Matsuo T; Tomonaga M
    Leuk Res; 1995 Feb; 19(2):121-5. PubMed ID: 7869740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. De-novo acute myeloid leukemia with trilineage myelodysplasia (AML/TMDS) and myelodysplastic remission marrow (AML/MRM).
    Tamura S; Kanamaru A
    Leuk Lymphoma; 1995 Jan; 16(3-4):263-70. PubMed ID: 7719234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The rate of disease progression predicts the quality of remissions following intensive chemotherapy for myelodysplastic syndromes.
    Hirst WJ; Mufti GJ
    Leuk Res; 1994 Nov; 18(11):797-804. PubMed ID: 7967705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and laboratory features of de novo acute myeloid leukaemia with trilineage myelodysplasia.
    Brito-Babapulle F; Catovsky D; Galton DA
    Br J Haematol; 1987 Aug; 66(4):445-50. PubMed ID: 3478074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Diagnosis and treatment strategy for de novo AML with trilineage myelodysplasia].
    Kuriyama K
    Rinsho Ketsueki; 1994 Mar; 35(3):267-71. PubMed ID: 8158847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytogenetic clonality analysis: typical patterns in myelodysplastic syndrome and acute myeloid leukaemia.
    van Lom K; Hagemeijer A; Vandekerckhove F; Smit EM; Löwenberg B
    Br J Haematol; 1996 Jun; 93(3):594-600. PubMed ID: 8652379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myelodysplastic relapse of de novo acute myeloid leukaemia with trilineage myelodysplasia: a previously unrecognized correlation.
    Brito-Babapulle F; Catovsky D; Galton DA
    Br J Haematol; 1988 Apr; 68(4):411-5. PubMed ID: 3163932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute erythroid neoplastic proliferations. A biological study based on 62 patients.
    Domingo-Claros A; Larriba I; Rozman M; Irriguible D; Vallespí T; Aventin A; Ayats R; Millá F; Solé F; Florensa L; Gallart M; Tuset E; Lopez C; Woessner S
    Haematologica; 2002 Feb; 87(2):148-53. PubMed ID: 11836165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapy-related acute myeloid leukemia/myelodysplasia with balanced 21q22 translocations.
    Arber DA; Slovak ML; Popplewell L; Bedell V; Ikle D; Rowley JD;
    Am J Clin Pathol; 2002 Feb; 117(2):306-13. PubMed ID: 11863228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erythroblastic and/or megakaryocytic dysplasia in de novo acute myeloid leukemias M0-M5 show relation to myelodysplastic syndromes and delimit two main categories.
    Lemez P; Gáliková J; Haas T
    Leuk Res; 2000 Mar; 24(3):207-15. PubMed ID: 10739003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Poor response to intensive chemotherapy in de novo acute myeloid leukaemia with trilineage myelodysplasia. Japan Adult Leukaemia Study Group (JALSG).
    Kuriyama K; Tomonaga M; Matsuo T; Kobayashi T; Miwa H; Shirakawa S; Tanimoto M; Adachi K; Emi N; Hiraoka A
    Br J Haematol; 1994 Apr; 86(4):767-73. PubMed ID: 7918070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of dysplastic features of hematopoiesis in patients with de novo acute myelogenous leukemia.
    Kahl C; Florschütz A; Müller G; Jentsch-Ullrich K; Arland M; Leuner S; Franke A; Höffkes HG
    Ann Hematol; 1997 Sep; 75(3):91-4. PubMed ID: 9368477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Morphologic dysplasia in de novo acute myeloid leukemia (AML) is related to unfavorable cytogenetics but has no independent prognostic relevance under the conditions of intensive induction therapy: results of a multiparameter analysis from the German AML Cooperative Group studies.
    Haferlach T; Schoch C; Löffler H; Gassmann W; Kern W; Schnittger S; Fonatsch C; Ludwig WD; Wuchter C; Schlegelberger B; Staib P; Reichle A; Kubica U; Eimermacher H; Balleisen L; Grüneisen A; Haase D; Aul C; Karow J; Lengfelder E; Wörmann B; Heinecke A; Sauerland MC; Büchner T; Hiddemann W
    J Clin Oncol; 2003 Jan; 21(2):256-65. PubMed ID: 12525517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone marrow dysplasia in patients with newly diagnosed acute myelogenous leukemia does not correlate with history of myelodysplasia or with remission rate and survival.
    Ballen KK; Gilliland DG; Kalish LA; Shulman LN
    Cancer; 1994 Jan; 73(2):314-21. PubMed ID: 8293394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute myeloid leukemia with t(6;9) (p23;q34): association with myelodysplasia, basophilia, and initial CD34 negative immunophenotype.
    Alsabeh R; Brynes RK; Slovak ML; Arber DA
    Am J Clin Pathol; 1997 Apr; 107(4):430-7. PubMed ID: 9124211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.